Rabimak of the tab. of p/o of 10 mg No. 30

tablets Rabimak belong to antiulcerous medicaments and medicaments for treatment of a gastroesophageal reflux.

to use at:

• active ulcer of a duodenum;
• active benign stomach ulcer;
• erosive or ulcer gastroesophageal reflux disease (GERD);
• long-term treatment of a gastroesophageal reflux disease (maintenance therapy of GERD);
• symptomatic treatment of a gastroesophageal reflux disease from moderated to very heavy degree (symptomatic treatment of GERD);
• Zollingera-Ellison's syndrome;
• in a combination with the corresponding antibacterial schemes for an eradikation of Helicobacter pylori (H. pylori) at patients with a peptic ulcer of a stomach and duodenum.

Structure

1 tablet supports a rabeprazol of 10 mg;

excipients: tablets on 10 mg the hydroksipropilmetiltsellyuloza low-substituted of magnesium attracts (E 421), oxide heavy, povidone, sodium hydroxide, talc, magnesium stearate, ethyl cellulose, ferrous oxide red (E172), the titan dioxide (E 171), methacrylate copolymer dispersion, triethyl citrate.

Contraindication

Drug is contraindicated to patients with hypersensitivity to a rabeprazol, substituted benzimidazole or to any other ingredient of drug.

Period of pregnancy and feeding by a breast.

Route of administration

Active ulcer of a duodenum and active benign stomach ulcer the recommended dose in these diseases makes 20 mg of 1 times a day in the morning. Course of treatment from 4 to 6 weeks.

Erosive or ulcer gastroesophageal reflux disease: the recommended dose in these diseases makes 20 mg of 1 times a day within 4-8 weeks.

Maintenance therapy of GERD: it is possible to apply maintenance doses of 10 mg or 20 mg of 1 times a day depending on the clinical answer of the patient to long-term treatment.

Symptomatic treatment of GERD from moderated to very heavy degree: to patients without esophagitis medicament to appoint in a dose 10 mg of 1 times a day. Course 4 weeks.

Zollingera-Ellison's Syndrome:

Recommended initial dose - 60 mg of 1 times a day. The dose can be raised gradually to 120 mg a day at clinical need. It is possible to apply a single dose to 100 mg a day. In need of reception of 120 mg a day the dose can be divided into 2 receptions on 60 mg. Duration of treatment depends on clinical need.

pylori: patients with N. of pylori should apply the corresponding combinations of medicament from eradikatsionny therapy. Appointment within 7 days is recommended:

Rabimak of 20 mg 2 times a day + klaritromitsin 500 mg 2 times a day and amoxicillin of 1 g 2 times a day.

Feature of use

Pregnant

Use is contraindicated to Rabimak during pregnancy.

during feeding a breast.

Rabimak is not recommended to appoint

to children as there is no sufficient experience of its use for patients of this age group now.

Drivers

Rabimak should not have negative effect on control of motor transport or other mechanisms. At emergence of drowsiness it is recommended to avoid control of motor transport or other mechanisms.

Experience intentional or accidental overdoses is limited to

.

Side effects

Infection and invasion: infections.

from mentality: insomnia, nervousness, depression.

from a respiratory system: cough, pharyngitis, rhinitis.

from nervous system: headache, dizziness, drowsiness.

from a digestive tract: often diarrhea, nausea, vomiting, abdominal pain, constipation, meteorism, benign fungicide polyp.

from a musculoskeletal system: nonspecific pain, dorsodynia.

General disorders: asthenia, grippopodobny syndrome, stethalgia, fever, pyrexia.

to Store

in original packing at a temperature not above 25 °C, out of children's reach.

Expiration date - 2 years.